Anti-DLL4 & VEGF Reference Antibody (Navicixizumab)

Product Overview

• Article Name: Anti-DLL4 & VEGF Reference Antibody (Navicixizumab)
• Biozol Catalog Number: SYB-CHBA058
• Supplier Catalog Number: CHBA058
• Alternative Catalog Number: SYB-CHBA058-100UG, SYB-CHBA058-1MG
• Manufacturer: Sanyou Bio
• Category: Antikörper
• Application: ELISA, FA, FACS, Kinetics

Product Description

Anti-CD3 & BCMA Reference Antibody (Teclistamab) (CHB454) is expressed from CHO, with a configuration of DuoBody. The heavy chain type is IgG4-SPFALA, and the light chain type is lambda.It has a predicted MW of 143.64 kDa.

Product Properties

• Concentration: 1mg/ml
• UniProt: Q9NR61
• Buffer: 25mM histidine, 8% sucrose, 0.01% Tween80 pH6.2
• Purity: >95%
• Form: Lyophilize
• Target: DLL4,VEGF